Anderson William F, Jatoi Ismail, Devesa Susan S
DHHS/NIH/NCI/Division of Cancer Prevention, EPN Suite 2144, 6130 Executive Blvd, Bethesda, MD, 20892, USA.
Breast Cancer Res Treat. 2005 Mar;90(2):127-37. doi: 10.1007/s10549-004-3777-3.
Breast cancer is a heterogeneous and chronic disease with relapses and death occurring 25 years or more after primary diagnosis. Standard tumor characteristics are used to predict initial relapse or death, but their ability to estimate long-term patterns of failure may be limited.
To further evaluate the significance of standard tumor features, we compared incidence and prognostic patterns in the National Cancer Institute's (NCI's) large-scale population-based Surveillance, Epidemiology, and End Results (SEER) program for high-risk versus low-risk breast cancers, i.e., size > 2.0 versus < or = 2.0 cm, lymph node positive versus negative, high versus low histologic grade, and hormone receptor negative versus positive expression, respectively. Data were stratified by age 50 years to approximate menopause.
High-risk versus low-risk breast cancers demonstrated two very different incidence and prognostic patterns. Age-specific incidence rates among women with high-risk tumors increased until age 50 years then flattened, whereas rates among women with low-risk tumors increased continuously with aging. Hazard rates for breast cancer death spiked sharply two years following primary breast cancer diagnosis among women with high-risk but not with low-risk tumors. Paradoxically, hazard function crossed over 6-8 years following breast cancer diagnosis, with hazard rates lower for high-risk than for low-risk breast cancers.
Distinct incidence and prognostic patterns among high-risk and low-risk breast cancers suggest a possible link between breast cancer etiology and outcome. These epidemiologic results appear to complement emerging molecular genetic techniques, showing distinct genotypes for high-risk and low-risk breast cancer phenotypes.
乳腺癌是一种异质性慢性疾病,在初次诊断后25年或更长时间会出现复发和死亡。标准肿瘤特征用于预测初始复发或死亡,但其估计长期失败模式的能力可能有限。
为进一步评估标准肿瘤特征的意义,我们在国立癌症研究所(NCI)基于大规模人群的监测、流行病学和最终结果(SEER)项目中,比较了高危与低危乳腺癌的发病率和预后模式,即肿瘤大小>2.0厘米与≤2.0厘米、淋巴结阳性与阴性、高组织学分级与低组织学分级,以及激素受体阴性与阳性表达。数据按50岁年龄分层以近似绝经状态。
高危与低危乳腺癌呈现出两种截然不同的发病率和预后模式。高危肿瘤女性的年龄别发病率在50岁前上升,之后趋于平稳,而低危肿瘤女性的发病率则随年龄持续上升。高危但非低危肿瘤女性在原发性乳腺癌诊断后两年,乳腺癌死亡风险率急剧飙升。矛盾的是,乳腺癌诊断后6 - 8年风险函数交叉,高危乳腺癌的风险率低于低危乳腺癌。
高危与低危乳腺癌不同的发病率和预后模式表明乳腺癌病因与结局之间可能存在联系。这些流行病学结果似乎补充了新兴的分子遗传学技术,显示出高危和低危乳腺癌表型具有不同的基因型。